F

FMC

Develops pesticides and sustainable agricultural solutions

Field Development Representative

Full-Time
No salary listed
Mid
Master's
Madera, CA, USA
Remote
Biology & BiotechClinical Research Operations

About the job

Requirements
  • A minimum Master of Science degree in Entomology, Plant Physiology, Plant Pathology, Weed Science, Plant Science, Agronomy, or another agricultural or related science is required.
  • Knowledge and experience in farming operations, including crop-specific ground preparation, equipment setup and operation, cultivation, irrigation, planting, spraying, and fertilizing.
  • Working knowledge of disease, insect, and weed biology and appropriate field-testing procedures, with technical competency in at least one of these disciplines.
  • Knowledge of agricultural cropping systems, pests, practices, and products, plus basic farm machinery operation and maintenance skills.
  • A state pesticide application license is required.
  • Possess or be working toward a Pest Control Advisor license and/or Certified Crop Advisor certification, and maintain certification through continuing education hours.
  • Commitment to safe driving practices, chemical handling, and equipment use; a driver's license is required.
  • Ability to work outdoors in hot and cold conditions and carry a 50-pound backpack sprayer over uneven ground.
  • Experience in field plot techniques and statistical data analysis; familiarity with ARM, FieldPro, or another data-recording system; and proficiency in Microsoft Office applications.
  • Ability to design protocols and research projects.
  • Strong written and oral communication skills in English.
  • Strong organizational skills and attention to detail, with the ability to independently manage time and priorities and deliver on commitments independently and collaboratively.
  • Ability to communicate with varied internal and external audiences in ways that promote understanding and build relationships.
Responsibilities
  • Manage contracted field tests and conduct in-house tests of synthetic and biological crop protection products for biological efficacy and crop safety in discovery and commercialization projects.
  • Plan, design, lay out, plant, treat, evaluate, and agronomically manage research trials.
  • Collect field research data, enter it into the corporate database promptly, and ensure data quality for all development trials conducted or managed.
  • Develop action plans and budgets that meet technical and operational objectives while managing time and priorities independently.
  • Provide input to marketing, sales, and technical service on market intelligence and business opportunities in the local territory as needed.
  • Summarize biological data and communicate results to support data-driven decisions.
  • Build working relationships with Product Development Managers and Technical Service Managers, and educate peers about field-trial observations and results to prepare for product launches.
  • Assist with on-site plot tours for internal and external audiences, partnering with Technical Service and the California Research and Technology Center teams in Madera.
  • Represent FMC and seek new talent at media summits, trade shows, and scientific society conferences.
Desired Qualifications
  • At least two years of experience in discovery, development, or commercialization of agricultural products is preferred; experience as a research assistant during postgraduate studies may count.
  • Bilingual skills are a plus.

About the company

FMC develops and supplies crop protection products, including herbicides, insecticides, and fungicides, plus formulations and technologies that help protect crops from pests and diseases. Its products work by using chemical active ingredients and tailored formulations that control pests while aiming to minimize environmental impact; the company emphasizes science-driven solutions to improve efficacy and safety in farming. Compared with competitors, FMC leverages a long history (over a century) and a clear focus on sustainable technologies that protect both crops and the environment, with ongoing discovery of new actives and innovative formulations. The company’s goal is to help feed the world’s growing population by delivering effective crop protection that is better for the planet.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Philadelphia, Pennsylvania

Founded

1883

Get referred to FMC

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Tessenderlo’s September 23, 2026 closing gives FMC immediate capital for deleveraging.
  • Management expects year-end 2026 net debt of $2.6 billion to $2.7 billion.
  • FMC’s Jefferies presentation targeted 2027 recovery from Rynaxypyr stabilization and new products.

What critics are saying

  • FMC’s Q2 2026 revenue fell 17% to $867 million, exposing severe demand weakness.
  • About 1,000 employees left under Project Foundation, signaling deeper operating disruption through Q1 2027.
  • If 2026 asset sales slip, FMC faces $4.4 billion debt and covenant pressure.

What makes FMC unique

  • FMC’s September 2026 Tessenderlo deal brought $403 million at $13.30, validating the turnaround.
  • Isoflex gained EU registration in April 2026, creating a differentiated launch platform for 2027.
  • FMC’s 2025 pipeline already delivered $200 million from three new actives, up 54%.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget
  • Family Planning Benefits
  • Mental Health Support

Company News

PR Newswire
Sep 23rd, 2026
Tessenderlo Group completes $403M minority stake investment in FMC Corporation

Tessenderlo Group has completed a minority equity investment in FMC Corporation, purchasing approximately 30.3 million shares at $13.30 per share for around $403 million. The Belgian industrial group now owns roughly 20% of the US agricultural sciences company's outstanding common stock. The transaction, first announced on 30 June 2026, received all necessary regulatory approvals. As part of the deal, Tessenderlo Group has the right to nominate one independent director to FMC's board and has put forward its chief executive officer, Luc Tack. Tessenderlo Group is subject to customary standstill restrictions and a three-year lock-up period on its shares. FMC develops crop protection solutions including biologicals and precision agriculture technologies. Tessenderlo Group, which operates in over 100 countries, recorded consolidated revenue of €2.8 billion in 2025.

Yahoo Finance
Jul 29th, 2026
FMC Corporation Q2 2026: $153M adjusted EBITDA beats guidance despite 17% revenue decline

FMC Corporation reported second quarter 2026 revenue of $867 million, down 17% year-over-year, with adjusted EBITDA of $153 million exceeding guidance. Excluding India, revenue fell 20% to $841 million, with organic revenue declining 22%. The company posted a GAAP net loss of $187 million, or $1.49 per diluted share. Adjusted earnings per share reached $0.26, down 62% from the prior year. Cash from operations rose significantly to $363 million, up $297 million year-over-year. FMC lowered its full-year outlook due to challenging macroeconomic conditions. The company now expects revenue excluding India of $3.50 billion to $3.70 billion and adjusted EBITDA between $620 million and $680 million. Free cash flow guidance increased to $75 million to $225 million, including a $200 million upfront licensing payment for rimisoxafen.

AInvest Fintech Inc.
Jul 1st, 2026
Tessenderlo to invest $400M for 20% stake in FMC at $13.30 per share

Tessenderlo Group has agreed to invest $400 million in FMC Corporation for a 20% stake at $13.30 per share, valuing the agricultural sciences company at approximately $2 billion. The transaction concludes FMC's strategic review initiated in February 2026 and supports its $1 billion debt reduction target. The Belgian industrial group described the investment as part of its strategy to acquire cornerstone minority stakes in high-quality agricultural companies. FMC said the agreement aligns with its operational plans, including advancing its R&D pipeline and commercialising new innovations. The deal follows recent FMC initiatives including a $1.2 billion bond offering, the $252 million sale of its India business, and a $200 million prepayment from Corteva. The transaction requires regulatory approvals and customary closing conditions.

MarketScreener
Jul 1st, 2026
FMC secures $400M from Tessenderlo Group to hit $1B debt paydown target

FMC Corporation, a global agricultural sciences company, has reached a definitive agreement with Belgian industrial group Tessenderlo Group for a $400 million minority equity investment at $13.30 per share. Upon completion, Tessenderlo Group will own approximately 20% of FMC's outstanding shares. The transaction concludes FMC's strategic options review announced in February 2026. FMC will use the proceeds to pay down debt, reaching its approximately $1 billion debt paydown target. Recent actions include raising $1.2 billion in secured bonds, selling its India commercial business for $252 million, and securing a $200 million prepayment from a Corteva agreement. The deal is subject to regulatory approvals. BofA Securities and Goldman Sachs advised FMC, whilst Stibbe and Sullivan & Cromwell advised Tessenderlo Group.

Simply Wall St
May 21st, 2026
FMC raises $750M in secured notes to ease leverage as dividend slashed 86%

FMC Corporation has raised $750 million through senior secured notes due 2031, issued under Regulation S and Rule 144A with guarantees. The fixed-income offering aims to strengthen the company's financial position and provide flexibility for operations, debt management and potential growth initiatives. The financing comes alongside a sharp dividend cut announced in April 2026, from $0.58 to $0.08 per share, signalling management's focus on cash preservation and balance sheet repair. FMC faces elevated leverage and weak interest coverage, making debt management the key near-term catalyst. Whilst the bond issue may ease short-term liquidity pressure, the company's investment narrative still depends on restoring profitability and cash generation in its crop protection business. Some analysts project FMC could reach $4.5 billion in revenue and $429 million in earnings.